These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8534045)

  • 41. Tuberculous meningitis in children: treatment with isoniazid and rifampicin for twelve months.
    Visudhiphan P; Chiemchanya S
    J Pediatr; 1989 May; 114(5):875-9. PubMed ID: 2715902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isoniazid Resistance and Dosage as Treatment for Patients with Tuberculosis.
    Nagel S; Streicher EM; Klopper M; Warren RM; Van Helden PD
    Curr Drug Metab; 2017; 18(11):1030-1039. PubMed ID: 29086682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis.
    Donald PR; Seifart HI
    J Pediatr; 1989 Sep; 115(3):483-6. PubMed ID: 2769511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of acute ethanol intake on isoniazid pharmacokinetics.
    Dattani RG; Harry F; Hutchings AD; Routledge PA
    Eur J Clin Pharmacol; 2004 Nov; 60(9):679-82. PubMed ID: 15568141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensive short course chemotherapy for tuberculous meningitis.
    Jacobs RF; Sunakorn P; Chotpitayasunonah T; Pope S; Kelleher K
    Pediatr Infect Dis J; 1992 Mar; 11(3):194-8. PubMed ID: 1565533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.
    Labana S; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2002 Oct; 20(4):301-4. PubMed ID: 12385689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.
    Schaaf HS; Parkin DP; Seifart HI; Werely CJ; Hesseling PB; van Helden PD; Maritz JS; Donald PR
    Arch Dis Child; 2005 Jun; 90(6):614-8. PubMed ID: 15908628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacokinetics of the antituberculosis drugs.
    Holdiness MR
    Clin Pharmacokinet; 1984; 9(6):511-44. PubMed ID: 6391781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoniazid Pharmacokinetics in the Presence of Ofloxacin and Norfloxacin Antibiotics.
    Anusiem CA; Brown SA; Ezejiofor NA; Barikpoar E; Orisakwe OE
    Am J Ther; 2018; 25(4):e397-e404. PubMed ID: 24451295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of tuberculosis and other mycobacterial diseases.
    Am Rev Respir Dis; 1983 Jun; 127(6):790-6. PubMed ID: 6859666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.
    Gent WL; Seifart HI; Parkin DP; Donald PR; Lamprecht JH
    Eur J Clin Pharmacol; 1992; 43(2):131-6. PubMed ID: 1425868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of isoniazid transfer into cerebrospinal fluid in patients with tuberculous meningitis.
    Shin SG; Roh JK; Lee NS; Shin JG; Jang IJ; Park CW; Myung HJ
    J Korean Med Sci; 1990 Mar; 5(1):39-45. PubMed ID: 2206465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigations on the Influence of Zidovudine in the Pharmacokinetics of Isoniazid and Its Hepatotoxic Metabolites in Rats.
    Ramanathan R; Sivanesan K
    J Pharm Pract; 2019 Feb; 32(1):9-18. PubMed ID: 29017426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and Side Effects of Rifampin versus Isoniazid in Children.
    Diallo T; Adjobimey M; Ruslami R; Trajman A; Sow O; Obeng Baah J; Marks GB; Long R; Elwood K; Zielinski D; Gninafon M; Wulandari DA; Apriani L; Valiquette C; Fregonese F; Hornby K; Li PZ; Hill PC; Schwartzman K; Benedetti A; Menzies D
    N Engl J Med; 2018 Aug; 379(5):454-463. PubMed ID: 30067928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of drug resistance on clinical outcome in children with tuberculous meningitis.
    Seddon JA; Visser DH; Bartens M; Jordaan AM; Victor TC; van Furth AM; Schoeman JF; Schaaf HS
    Pediatr Infect Dis J; 2012 Jul; 31(7):711-6. PubMed ID: 22411053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bilateral optic neuritis due to isoniazid (INH).
    Kulkarni HS; Keskar VS; Bavdekar SB; Gabhale Y
    Indian Pediatr; 2010 Jun; 47(6):533-5. PubMed ID: 20622286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum and cerebrospinal fluid concentrations of rifampicin at two dose levels in children with tuberculous meningitis.
    Mahajan M; Rohatgi D; Talwar V; Patni SK; Mahajan P; Agarwal DS
    J Commun Dis; 1997 Sep; 29(3):269-74. PubMed ID: 9465533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tuberculous meningitis in children before and since isoniazid.
    Mintz AA
    South Med J; 1976 Aug; 69(8):1061-2. PubMed ID: 959874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.